BioLineRx’s BL-8040 gets FDA Orphan Drug Designation for stem cell … – News-Medical.net
|
BioLineRx’s BL-8040 gets FDA Orphan Drug Designation for stem cell …
News-Medical.net The Orphan Drug Designation was granted for use of BL-8040, in combination with granulocyte colony-stimulating factor (G-CSF), to mobilize human stem cells from the bone marrow to the peripheral blood for collection for autologous or allogeneic … |
